| 1041-P: Health Care Transition Practices in the T1D Exchange Quality Improvement Collaborative F MALIK, J CASES-VILLABLANCA, ME HILLIARD, S LYONS, ... Diabetes 72 (Supplement_1), 2023 | | 2023 |
| 11-OR: Assessments of Prediagnostic Metabolic Measures as Surrogate Endpoints for Type 1 Diabetes (T1D) Prevention Trials EK Sims, DD Cuthbertson, LM Jacobsen, KC Herold, JAY Sosenko Diabetes (New York, NY) 70 (Supplement_1), 2021 | | 2021 |
| 1255-P: IA-2A Autoantibody Titers Predict Subsequent Divergence between Nonprogressors (NP) and Progressors (P) to Type 1 Diabetes with Similar Degree of Initial Metabolic … EK Sims, DD Cuthbertson, LM Jacobsen, HM Ismail, BM Nathan, ... Diabetes 71 (Supplement_1), 2022 | | 2022 |
| 1293-P: Real-World Status of Autoantibody Screening and Teplizumab Administration Readiness among Centers Participating in the T1D Exchange Quality Improvement Collaborative … C DEMETERCO-BERGGREN, LM JACOBSEN, I GUTTMANN-BAUMAN, ... Diabetes 73 (Supplement_1), 2024 | | 2024 |
| 1366-P: Effect of Substance Use on Type 1 Diabetes (T1D) Pancreas Histopathology BS Bruggeman, M Campbell-Thompson, AL Posgai, MA Atkinson, ... Diabetes 68 (Supplement_1), 2019 | | 2019 |
| 1440-P: Single Islet Antigen 2 Antibody–Positive (IA2A Ab+) Children Exhibit Significant Metabolic Abnormalities and 5-Year Type 1 Diabetes (T1D) Risk EK SIMS, DD CUTHBERTSON, E BOSI, C EVANS-MOLINA, ... Diabetes 72 (Supplement_1), 2023 | | 2023 |
| 1441-P: Index60 Stratification Enhances Current Staging for Type 1 Diabetes by Identifying At-Risk Single Islet Autoantibody Positive (Ab+) Individuals EK SIMS, DD CUTHBERTSON, E BOSI, C EVANS-MOLINA, ... Diabetes 72 (Supplement_1), 2023 | | 2023 |
| 1445-P: A Glucose Fraction Independent of Insulin Secretion in Autoantibody Positive (Ab+) Individuals JAY SOSENKO, DD CUTHBERTSON, MJ REDONDO, HM ISMAIL, ... Diabetes 72 (Supplement_1), 2023 | | 2023 |
| 1447-P: Metabolic Heterogeneity of Antibody-Positive Individuals (Ab+ I) with Impaired Glucose Tolerance (IGT) according to Glucose Fractions BM NATHAN, DD CUTHBERTSON, HM ISMAIL, LM JACOBSEN, ... Diabetes 73 (Supplement_1), 2024 | | 2024 |
| 1448-P: The Role of a Glucose Fraction Independent of Insulin Secretion in Predicting Hyperglycemia Endpoints in Autoantibody-Positive Individuals (Ab+ I) BM NATHAN, DD CUTHBERTSON, HM ISMAIL, LM JACOBSEN, ... Diabetes 73 (Supplement_1), 2024 | | 2024 |
| 1455-P: The Oral Disposition Index (ODI) and Its Components during the Progression of Autoantibody-Positive (Ab+) Individuals to Type 1 Diabetes (T1D) HM ISMAIL, DD CUTHBERTSON, LM JACOBSEN, MA ATKINSON, ... Diabetes 73 (Supplement_1), 2024 | | 2024 |
| 1460-P: Antibody+ (Ab+) Individuals with Marked Metabolic Heterogeneity at Screening Have Similar Evolution in the Progression to Type 1 Diabetes (T1D) with Converging … EK SIMS, LM JACOBSEN, HM ISMAIL, MJ REDONDO, BM NATHAN, ... Diabetes 73 (Supplement_1), 2024 | | 2024 |
| 1618-P: Insulin Secretion Variability According to the Specific Type 1 Diabetes (T1D) Risk Predictor LM Jacobsen, BM Nathan, HM Ismail, MJ Redondo, D Schatz, MJ Haller, ... Diabetes 69 (Supplement_1), 2020 | | 2020 |
| 1637-P: Role of mTORC1 Regulation in the T1D Organ Donor Pancreas BS Bruggeman, D Beachy, LM Jacobsen, HS Nick, MA Atkinson, D Schatz, ... Diabetes 69 (Supplement_1), 2020 | | 2020 |
| 164-OR: Efficacy of New-Onset Type 1 Diabetes (T1D) Intervention Trials: Variation in 1-Year Outcomes MJ Haller, MN Greco, D Schatz, MA Atkinson, TM Brusko, CE Mathews, ... Diabetes 68 (Supplement_1), 2019 | | 2019 |
| 1678-P: Comparisons of Combined C-Peptide and Glucose Intermediate Endpoints for Identifying Individuals at Very High Risk for Type 1 Diabetes LM Jacobsen, MA Clements, MJ Redondo, BM Nathan, D Schatz, ... Diabetes 68 (Supplement_1), 2019 | | 2019 |
| 1684-P: Using Index60 to Detect Heterogeneity and Identify Subpopulations with Characteristic Type 1 Diabetes (T1D) Profiles among Individuals with Normal Two-Hour Glucose Levels BM NATHAN, S GEYER, LE BOCCHINO, JP PALMER, LM JACOBSEN, ... Diabetes 68 (Supplement_1), 2019 | | 2019 |
| 330-OR: Narrow Variation of Glucose Inflection Points (IPs) during Progression to Type 1 Diabetes (T1D) Stratified by Demographic and Genetic Differences in Autoantibody … HM ISMAIL, DD CUTHBERTSON, LM JACOBSEN, BM NATHAN, ... Diabetes 73 (Supplement_1), 2024 | | 2024 |
| 350-OR: The Oral Disposition Index (ODI) Predicts Type 1 Diabetes (T1D) in Autoantibody-Positive (Ab+) Individuals HM Ismail, DD Cuthbertson, MJ Redondo, LM Jacobsen, MA Atkinson, ... Diabetes 71 (Supplement_1), 2022 | | 2022 |
| 589-P: Effect of Oral Insulin (OI) on Combined Glucose and C-Peptide Endpoints in Individuals at High-Risk for Type 1 Diabetes (T1D) LM Jacobsen, DD Cuthbertson, EK Sims, HM Ismail, L Dimeglio, ... Diabetes (New York, NY) 70 (Supplement_1), 2021 | | 2021 |
